Cargando…
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210944/ https://www.ncbi.nlm.nih.gov/pubmed/35747830 http://dx.doi.org/10.3389/fonc.2022.889996 |
| _version_ | 1784730262214541312 |
|---|---|
| author | Awad, Mark M. Le Bruchec, Yvan Lu, Brian Ye, Jason Miller, Julie Ann Lizotte, Patrick H. Cavanaugh, Megan E. Rode, Amanda J. Dumitru, Calin Dan Spira, Alexander |
| author_facet | Awad, Mark M. Le Bruchec, Yvan Lu, Brian Ye, Jason Miller, Julie Ann Lizotte, Patrick H. Cavanaugh, Megan E. Rode, Amanda J. Dumitru, Calin Dan Spira, Alexander |
| author_sort | Awad, Mark M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9210944 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92109442022-06-22 Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study Awad, Mark M. Le Bruchec, Yvan Lu, Brian Ye, Jason Miller, Julie Ann Lizotte, Patrick H. Cavanaugh, Megan E. Rode, Amanda J. Dumitru, Calin Dan Spira, Alexander Front Oncol Oncology Frontiers Media S.A. 2022-06-07 /pmc/articles/PMC9210944/ /pubmed/35747830 http://dx.doi.org/10.3389/fonc.2022.889996 Text en Copyright © 2022 Awad, Le Bruchec, Lu, Ye, Miller, Lizotte, Cavanaugh, Rode, Dumitru and Spira https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Awad, Mark M. Le Bruchec, Yvan Lu, Brian Ye, Jason Miller, Julie Ann Lizotte, Patrick H. Cavanaugh, Megan E. Rode, Amanda J. Dumitru, Calin Dan Spira, Alexander Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study |
| title | Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study |
| title_full | Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study |
| title_fullStr | Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study |
| title_full_unstemmed | Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study |
| title_short | Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study |
| title_sort | corrigendum: selective histone deacetylase inhibitor acy-241 (citarinostat) plus nivolumab in advanced non-small cell lung cancer: results from a phase ib study |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210944/ https://www.ncbi.nlm.nih.gov/pubmed/35747830 http://dx.doi.org/10.3389/fonc.2022.889996 |
| work_keys_str_mv | AT awadmarkm corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT lebruchecyvan corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT lubrian corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT yejason corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT millerjulieann corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT lizottepatrickh corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT cavanaughmegane corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT rodeamandaj corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT dumitrucalindan corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy AT spiraalexander corrigendumselectivehistonedeacetylaseinhibitoracy241citarinostatplusnivolumabinadvancednonsmallcelllungcancerresultsfromaphaseibstudy |